Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
Drug Transporter (DT) Information
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0239 | ||||
| Gene Name | SLC27A2 | ||||
| Protein Name | Very long-chain acyl-CoA synthetase | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
| Synonyms | ACSVL1; FACVL1; FATP-2; FATP2; Fatty acid transport protein 2; Fatty-acid-coenzyme A ligase, very long-chain 1; HsT17226; Long-chain-fatty-acid--CoA ligase; SLC27A2; Solute carrier family 27 member 2; THCA-CoA ligase; VLACS; VLCS; Very long-chain-fatty-acid-CoA ligase; hFACVL1 | ||||
| DT Family | Fatty Acid Transporter (FAT) Family ; | ||||
| Tissue Specificity | Expressed in liver, kidney, placenta andpancreas. | ||||
| Function | This transporter convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. | ||||
| Endogenous Substrate(s) | Fatty acids | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.